N03AX12 |
G |
Gabapentin - 400mg |
6312 |
24971/07 |
GABANET 400 |
400mg |
48 |
Capsule |
Oral |
C. Catafago & Co |
The Jordanian Pharmaceutical Manufacturing Co. (JPM) |
Jordan |
1,607,236 L.L |
23.08 |
B |
The Jordanian Pharmaceutical Manufacturing & Co Ltd |
Jordan |
04/03/20 |
|
N03AX12 |
G |
Gabapentin - 400mg |
8705 |
85316/1 |
GABAPENTINE ARROW GENERIQUES |
400mg |
90 |
Capsule |
Oral |
Darapharma S.A.L. |
APL Swift Services (Malta) Limited |
Malta |
1,342,499 L.L |
23.08 |
A2 |
Arrow Génériques |
France |
04/03/20 |
|
N03AX12 |
G |
Gabapentin - 400mg |
11973 |
102923/1 |
GABAPENTINE ARROW GENERIQUES |
400mg |
90 |
Capsule |
Oral |
Darapharma S.A.L. |
Generis Farmaceutica SA |
Portugal |
1,342,499 L.L |
23.08 |
A2 |
Arrow Génériques |
France |
04/03/20 |
|
N03AX12 |
G |
Gabapentin - 400mg |
6621 |
24990/07 |
GABATREX |
400mg |
50 |
Capsule |
Oral |
Abela Frères S.A.L. |
Hikma Pharmaceuticals |
Jordan |
1,846,440 L.L |
23.08 |
B |
Hikma Pharmaceuticals |
Jordan |
04/03/20 |
|
N03AX12 |
G |
Gabapentin - 400mg |
6569 |
218591/10 |
NEUROPLEX |
400mg |
50 |
Capsule |
Oral |
Mersaco |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
1,290,089 L.L |
23.08 |
A2 |
Tabuk Pharmaceutical Manufacturing Company |
Saudi Arabia |
04/03/20 |
|
N03AX12 |
G |
Gabapentin - 400mg |
6327 |
167453/10 |
PMS-GABAPENTIN |
400mg |
50 |
Capsule |
Oral |
UPO S.A.L. |
Pharmascience Inc |
Canada |
1,071,042 L.L |
23.08 |
A2 |
Pharmascience Inc |
Canada |
04/03/20 |
|